Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Search for FDA Guidance Documents

Search for FDA Guidance Documents

                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents Home
          Regulatory Information
          Search for FDA Guidance Documents
          510(k) Third Party Review ProgramSearch for FDA Guidance Documents GUIDANCE DOCUMENT
	510(k) Third Party Review Program
					Guidance for Industry, Food and Drug Administration Staff, and Third Party Review Organizations
		
		March 2020


	Download the  Final Guidance Document 

    Final

	  
	  
	Share
    Post
    Linkedin

    Email
    PrintDocket Number:
		    FDA-2016-D-2565
	    	    		    Issued by:
		    Guidance Issuing Office
          Center for Devices and Radiological Health


The 510(k) Third Party (3P510k) Review Program (formally known as the Accredited Persons (AP) Program) is authorized under section 523 of the Federal Food, Drug, and Cosmetic (FD&C) Act.1 Under this authority, FDA recognizes third parties to review premarket notification (510(k)) submissions and recommend the initial classification of certain devices. FDA's implementation of section 523 establishes a process for recognition of qualified third parties to conduct the initial review of 510(k) submissions for certain low-to-moderate risk devices eligible for review under the 3P510k Review Program within the Center for Devices and Radiological Health (CDRH).2 This guidance document also reflects amendments made to section 523 by the FDA Reauthorization Act of 2017 (FDARA),3 which directed FDA to issue guidance4 on the factors that will be used in determining whether a class I or class II device type, or subset of such device types, is eligible for review by an accredited person.

For the current edition of the FDA-recognized standards referenced in this document, see the FDA Recognized Consensus Standards Database.5 For more information regarding use of consensus standards in regulatory submissions, please refer to FDA guidance entitled, "Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices".6

The objectives of this guidance are:

To describe the factors FDA will use in determining device type eligibility for review by 3P510k Review Organizations
	To outline FDA's process for the recognition, rerecognition, suspension, and withdrawal of recognition for 3P510k Review Organizations
	To ensure consistent quality of work among 3P510k Review Organizations through the Medical Device User Fee Amendments (MDUFA) IV commitments authorized under FDARA7 to eliminate the need for routine, substantive re-review by FDA.81 Section 523 of the FD&C Act uses the terms "accredited persons," "accredit," "accredited," "accreditation," "reaccredit," "reaccredited," and "reaccreditation." The guidance does not use those statutory terms but rather defines such terms as "recognition," and "rerecognition" as synonymous terms. These alternative terms are used in this guidance to harmonize the terms used by FDA and in the FD&C Act with those in the International Medical Device Regulators Forum (IMDRF) Medical Device Single Audit Program (MDSAP) documents and are defined in Section IV of this guidance.

2 Currently, the Center for Biologics Evaluation and Research does not regulate devices of the types subject to this guidance.

3 Pub. L. 115-52

4 See section 523(a)(3)(B) of the FD&C Act.

5 Available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm.

6 See Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices.

7 Pub L. 115-52

8 See Eliminating Routine FDA Re-Review of Third Party 510(k) Reviews.


 
	Submit Comments
	   		  			    		Submit Comments Online
					You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
						If unable to submit comments online, please mail written comments to:
						Dockets Management
							Food and Drug Administration
							5630 Fishers Lane, Rm 1061
							Rockville, MD 20852
						All written comments should be identified with this document's docket number: FDA-2016-D-2565.

                                                                                  Content current as of:
      03/12/2020
         
                  
Regulated Product(s)
		 Medical DevicesTopic(s)
			  Premarket
				    				       				    					
				  
				  
				  
				  				  510(k)
				  				     				  				  
				   
				  
				  				  Administrative / ProceduralLaw(s) & Regulation(s)
			  FDA Safety and Innovation Act (FDASIA)Search for FDA Guidance Documents

        Search for FDA Guidance Documents

          
                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop